trends in prescribing of and spending on digoxin in general practice in england © copyright nhsbsa...
TRANSCRIPT
Trends in Prescribing of and Spending on Digoxin in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
£0
£500,000
£1,000,000
£1,500,000
£2,000,000
£2,500,000
£3,000,000
£3,500,000
£4,000,000
NIC
(£)
Items NIC
© Copyright NHSBSA 2009
Trends in Prescribing of Thiazides and Related Diuretics in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
Bendroflumethiazide Indapamide Others
© Copyright NHSBSA 2009
Trends in Spending on Thiazides and Related Diuretics in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
NIC
(£)
Bendroflumethiazide Indapamide Others
© Copyright NHSBSA 2009
Trends in Prescribing of Bendroflumethiazide Tabs/Caps in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
2.5mg 5mg
© Copyright NHSBSA 2009
Trends in Prescribing of Spironolactone Caps/Tabs in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
25mg 50mg 100mg
© Copyright NHSBSA 2009
Trends in Prescribing of Potassium-sparing Diuretics in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Spironolactone Amiloride
Eplerenone Triamterene
© Copyright NHSBSA 2009
Trends in Spending on Potassium-sparing Diuretics in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
Sep
-03
Dec-03
Mar-04
Jun-04
Sep
-04
Dec-04
Mar-05
Jun-05
Sep
-05
Dec-05
Mar-06
Jun-06
Sep
-06
Dec-06
Mar-07
Jun-07
Sep
-07
Dec-07
Mar-08
Jun-08
Sep
-08
Quarter to
NIC
(£)
Spironolactone Amiloride
Eplerenone Triamterene
© Copyright NHSBSA 2009
Trends in Prescribing of Potassium-sparing Diuretics with Other Diuretics in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
1,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Amiloride + loop diuretic Amiloride + thiazide Triamterene + thiazide Others
© Copyright NHSBSA 2009
Trends in Spending on Potassium-sparing Diuretics with Other Diuretics in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Amiloride + loop diuretic Amiloride + thiazide Triamterene + thiazide Others
© Copyright NHSBSA 2009
Trends in Prescribing of and Spending on Amiodarone in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
£0
£200,000
£400,000
£600,000
£800,000
£1,000,000
£1,200,000
£1,400,000
£1,600,000
£1,800,000
£2,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2009
Trends in Prescribing of Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Atenolol Bisoprolol Propranolol Metoprolol SotalolCarvedilol Nebivolol Others Combinations
© Copyright NHSBSA 2009
Trends in Spending on Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Atenolol Bisoprolol Propranolol Metoprolol SotalolCarvedilol Nebivolol Others Combinations
© Copyright NHSBSA 2009
Trends in Prescribing of Alpha-adrenoceptor Blocking Drugs in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
Doxazosin Prazosin Terazosin Others
© Copyright NHSBSA 2009
Trends in Spending on Alpha-adrenoceptor Blocking Drugs in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Doxazosin Prazosin Terazosin Others
© Copyright NHSBSA 2009
% Ratio of Prescribing of ACE Inhibitors vs Angiotensin-II Receptor Antagonists
0%
20%
40%
60%
80%
100%
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
% o
f al
l ite
ms
ACE Inhibitors Angiotensin-II Receptor Antagonists
© Copyright NHSBSA 2009
% Ratio of Spending on ACE Inhibitors vs Angiotensin-II Receptor Antagonists
0%
20%
40%
60%
80%
100%
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
% o
f N
IC (
£)
ACE Inhibitors Angiotensin-II Receptor Antagonists
© Copyright NHSBSA 2009
Trends in Prescribing of ACE Inhibitors (including combinations) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
10,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Ramipril Lisinopril Perindopril Enalapril Combinations Others
© Copyright NHSBSA 2009
Trends in Spending on ACE Inhibitors (including combinations) in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
80,000,000
90,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Ramipril Lisinopril Perindopril Enalapril Combinations Others
© Copyright NHSBSA 2009
Trends in Prescribing of Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Losartan Candesartan Irbesartan Valsartan Combinations Others
© Copyright NHSBSA 2009
Trends in Spending on Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
80,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Losartan Candesartan Irbesartan Valsartan Combinations Others
© Copyright NHSBSA 2009
Trends in Prescribing of Nitrates in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
Isosorbide Mononitrate Glyceryl Trinitrate Isosorbide Dinitrate
© Copyright NHSBSA 2009
Trends in Spending on Nitrates in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
18,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
NIC
(£)
Isosorbide Mononitrate Glyceryl Trinitrate Isosorbide Dinitrate
© Copyright NHSBSA 2009
Trends in Prescribing of Calcium-channel Blockers in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Amlodipine Nifedipine DiltiazemFelodipine Lercanidipine Verapamil Others
© Copyright NHSBSA 2009
Trends in Spending on Calcium-channel Blockers in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
80,000,000
90,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Amlodipine Nifedipine DiltiazemFelodipine Lercanidipine Verapamil Others
© Copyright NHSBSA 2009
Trends in Prescribing of and Spending on Nicorandil in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
£0
£1,000,000
£2,000,000
£3,000,000
£4,000,000
£5,000,000
£6,000,000
£7,000,000
NIC
(£)
Items NIC
© Copyright NHSBSA 2009
Trends in Prescribing of Peripheral Vasodilators in General Practice in England
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
100,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
Naftidrofuryl Oxerutins Pentoxifylline Nicotinic Acid Derivatives Cilostazol Others
© Copyright NHSBSA 2009
Trends in Spending on Peripheral Vasodilators in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Naftidrofuryl Oxerutins Pentoxifylline Nicotinic Acid Derivatives Cilostazol Others
© Copyright NHSBSA 2009
Trends in Prescribing of and Spending on Warfarin in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
£0
£1,000,000
£2,000,000
£3,000,000
£4,000,000
£5,000,000
£6,000,000
£7,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2009
Trends in Prescribing of Antiplatelet Drugs in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Aspirin Clopidogrel Dipyridamole Others
© Copyright NHSBSA 2009
Trends in Spending on Antiplatelet Drugs in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Aspirin Clopidogrel Dipyridamole Others
© Copyright NHSBSA 2009
Trends in Prescribing of Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Others E/C
© Copyright NHSBSA 2009
Trends in Spending on Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
NIC
(£)
Others E/C
© Copyright NHSBSA 2009
Trends in Prescribing of Lipid-regulating Drugs (excluding Statins) in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Bezafibrate Fenofibrate Omega-3 Ciprofibrate Colestyramine Others
NB. Excluding Ezetimibe
© Copyright NHSBSA 2009
Trends in Spending on Lipid-regulating Drugs (excluding Statins) in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Bezafibrate Fenofibrate Omega-3 Ciprofibrate Colestyramine Others
NB. Excluding Ezetimibe
© Copyright NHSBSA 2009
Trends in Prescribing of and Spending on Ezetimibe in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
£0
£2,000,000
£4,000,000
£6,000,000
£8,000,000
£10,000,000
£12,000,000
£14,000,000
£16,000,000
£18,000,000
£20,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2009
Trends in Prescribing of Fibrates in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Bezafibrate Fenofibrate Ciprofibrate Gemfibrozil
© Copyright NHSBSA 2009
Trends in Spending on Fibrates in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Bezafibrate Fenofibrate Ciprofibrate Gemfibrozil
© Copyright NHSBSA 2009
Trends in Prescribing of Nicotinic Acid Group Drugs in General Practice in England
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Nicotinic Acid Acipimox
© Copyright NHSBSA 2009
Trends in Spending on Nicotinic Acid Group Drugs in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
Sep
-03
Dec-03
Mar-04
Jun-04
Sep
-04
Dec-04
Mar-05
Jun-05
Sep
-05
Dec-05
Mar-06
Jun-06
Sep
-06
Dec-06
Mar-07
Jun-07
Sep
-07
Dec-07
Mar-08
Jun-08
Sep
-08
Quarter to
NIC
(£)
Nicotinic Acid Acipimox
© Copyright NHSBSA 2009
Trends in Prescribing of Statins in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
Simvastatin Atorvastatin Pravastatin Rosuvastatin Others
© Copyright NHSBSA 2009
Trends in Spending on Statins in General Practice in England
0
50,000,000
100,000,000
150,000,000
200,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
Simvastatin Atorvastatin Pravastatin Rosuvastatin Others
© Copyright NHSBSA 2009
Trends in Prescribing of Atorvastatin Tabs by Strength in General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
10mg 20mg 40mg 80mg
© Copyright NHSBSA 2009
Trends in Spending on Atorvastatin Tabs by Strength in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
40,000,000
45,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
10mg 20mg 40mg 80mg
© Copyright NHSBSA 2009
Trends in Prescribing of Simvastatin Tabs by Strength in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
10mg 20mg 40mg 80mg
© Copyright NHSBSA 2009
Trends in Spending on Simvastatin Tabs by Strength in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
40,000,000
45,000,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
NIC
(£)
10mg 20mg 40mg 80mg
© Copyright NHSBSA 2009
Trends in Prescribing of Rosuvastatin by Strength in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
Item
s
5mg 10mg 20mg 40mg
© Copyright NHSBSA 2009
Trends in Spending on Rosuvastatin by Strength in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
NIC
(£)
5mg 10mg 20mg 40mg
© Copyright NHSBSA 2009
Trends in Prescribing of and Spending on Inegy® in General Practice in England
0
10,000
20,000
30,000
40,000
50,000
60,000
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Quarter to
Item
s
£0
£500,000
£1,000,000
£1,500,000
£2,000,000
£2,500,000
£3,000,000
NIC
(£)
Items NIC
© Copyright NHSBSA 2009
% Ratio of Prescribing of High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®)
vs All Other Statins in General Practice in England
0%
20%
40%
60%
80%
100%
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
% o
f It
ems
All other Statins High Strength
© Copyright NHSBSA 2009
% Ratio of Spending on High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®)
vs All Other Statins in General Practice in England
0%
20%
40%
60%
80%
100%
Sep
-03
Dec-03
Mar-04
Jun
-04
Sep
-04
Dec-04
Mar-05
Jun
-05
Sep
-05
Dec-05
Mar-06
Jun
-06
Sep
-06
Dec-06
Mar-07
Jun
-07
Sep
-07
Dec-07
Mar-08
Jun
-08
Sep
-08
Quarter to
% o
f N
IC (
£)
All other Statins High Strength
© Copyright NHSBSA 2009